Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma

被引：70

作者：

Morton, DL ^{[1
]}

Ollila, DW

Hsueh, EC

Essner, R

Gupta, RK

机构：

[1] St Johns Hlth Ctr, John Wayne Ctr Inst, Santa Monica, CA USA

[2] Univ N Carolina, Chapel Hill, NC 27515 USA

[3] John Wayne Ctr Inst, Lab Prot Biochem & Tumor Markers, Santa Monica, CA USA

来源：

CA-A CANCER JOURNAL FOR CLINICIANS | 1999年 / 49卷 / 02期

关键词：

D O I：

10.3322/canjclin.49.2.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although patients with metastatic disease are usually not offered surgery as part of their comprehensive treatment plan, the authors suggest that surgical reduction of the tumor burden may enhance the host immune response and create a favorable setting for the use of active specific immunotherapy.

引用

页码：101 / +

页数：17

共 84 条

[1] ADSON MA, 1984, ARCH SURG-CHICAGO, V119, P647
[2] Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck
Avradopoulos, K
Mehta, S
Blackinton, D
Wanebo, HJ
[J]. ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (02) : 184 - 190
[3] BARTH A, 1995, CANCER, V75, P726, DOI 10.1002/1097-0142(19950115)75:2+<726::AID-CNCR2820751417>3.0.CO
[4] 2-R
[5] Barth A, 1995, J Am Coll Surg, V181, P193
[6] BATCHELOR JR, 1989, IMMUNOL TODAY, V10, P37
[7] Bystryn J C, 1995, Recent Results Cancer Res, V139, P337
[8] CHAKRABORTY NG, 1990, J IMMUNOL, V145, P2359
[9] Quality-of-life - adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study
Cole, BF
Gelber, RD
Kirkwood, JM
Goldhirsch, A
Barylak, E
Borden, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2666 - 2673
[10] 100 PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL-CANCER TREATED BY RESECTION - ANALYSIS OF PROGNOSTIC DETERMINANTS
DOCI, R
GENNARI, L
BIGNAMI, P
MONTALTO, F
MORABITO, A
BOZZETTI, F
[J]. BRITISH JOURNAL OF SURGERY, 1991, 78 (07) : 797 - 801

← 1 2 3 4 5 6 7 8 9 →